Core Viewpoint - American Battery Technology Company is under investigation for potential securities fraud following the termination of a significant grant from the U.S. Department of Energy, which has led to a substantial decline in its stock price [1][2]. Group 1: Investigation Details - Pomerantz LLP is investigating claims on behalf of investors of American Battery Technology Company regarding possible securities fraud or unlawful business practices by the company and its officers/directors [1]. - The investigation was prompted by the disclosure that the U.S. Department of Energy terminated a grant that would have provided $57.7 million for the construction of a commercial scale facility for manufacturing battery cathode grade lithium hydroxide [2]. Group 2: Financial Impact - Following the announcement of the grant termination, American Battery's stock price dropped by $6.48 per share, representing a 57.19% decline, closing at $1.85 per share on October 17, 2025 [2].

Core Insights - Pomerantz LLP is investigating claims on behalf of investors of Jumia Technologies AG regarding potential securities fraud or unlawful business practices [1] - Aletheia Capital downgraded Jumia from Buy to Sell due to concerns about its net working capital position, considering recent improvements as temporary and unsustainable [2] - Following the downgrade, Jumia's ADR price fell by $1.13, or 9.51%, closing at $10.75 on October 17, 2025 [2] Company Overview - Jumia Technologies AG is listed on the NYSE under the ticker JMIA and operates in the e-commerce sector [1] - The company has faced scrutiny regarding its financial practices and stock valuation compared to peers [2] Legal Context - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a history of recovering significant damages for victims of securities fraud [3]

Core Viewpoint - Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of Fluence Energy, Inc. (NASDAQ: FLNC) [1] Group 1: Allegations and Background - A securities class action alleges that Fluence's relationship with its founders and major revenue sources, Siemens AG and The AES Corporation, is expected to decline [2] - Siemens Energy has accused Fluence of engineering failures and fraud, impacting the company's credibility [2] - Fluence's reported margins and revenue growth are claimed to be inflated as Siemens and AES are moving towards divestment [2] - The defendants allegedly lacked a reasonable basis for their positive statements regarding Fluence's battery energy storage business and financial outlook [2] Group 2: Shareholder Rights and Legal Support - Long-term shareholders of Fluence who have held shares since before October 28, 2021, may have standing to seek corporate governance reforms [2] - Johnson Fistel offers evaluation of potential claims at no cost to qualifying long-term investors [3] Group 3: About Johnson Fistel - Johnson Fistel, PLLP is a nationally recognized law firm specializing in shareholder rights and securities fraud, with offices across multiple states [4] - The firm has achieved significant recoveries for clients, totaling approximately $90,725,000 in cases where it served as lead or co-lead counsel [5]

Core Viewpoint - James Hardie Industries plc is under investigation for potential violations of federal securities laws, with concerns regarding the sustainability of its North American sales growth [1][3]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement and fiber gypsum building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [2]. Sales Performance - The company claimed that its "fast[]-growing customers" were a key aspect of its competitive positioning, asserting strong North American business results [3]. - However, it appears that North American sales may have been artificially inflated due to temporary inventory loading by channel partners rather than genuine customer demand [3]. Financial Results and Stock Impact - On August 19, 2025, James Hardie reported a 12% decline in North American net sales for fiscal Q1 2026, attributing this to customers returning to normal inventory levels [4]. - Following this announcement, the stock price plummeted by $9.79 per share, a decrease of over 34%, from $28.43 to $18.64 [4].

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws. If you invested in Jefferies or Point Bonita, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/jefferies-financial-group-inc-class-action. Why are Jefferies and Point Bonita being Investigated? Jefferies is an i ...

Core Viewpoint - BellRing Brands, Inc. is under investigation for potential violations of federal securities laws, with concerns regarding the sustainability of its sales growth driven by temporary trade inventory loading rather than genuine consumer demand [1][2]. Company Overview - BellRing Brands operates in the convenient nutrition category, primarily known for its brands Premier Protein and Dymatize, which offer ready-to-drink protein shakes and powders [2]. Sales Performance - The company reported that Premier Protein achieved an all-time high in household penetration and strong demand across all channels, attributed to distribution expansion and promotional activities [2]. - However, the actual sales growth may have been artificially inflated due to temporary inventory loading at key retailers, raising questions about the sustainability of this growth [2]. Stock Market Reaction - On May 5, 2025, BellRing disclosed that several key retailers reduced their inventory levels, which would negatively impact growth in Q3 2025. Following this announcement, the stock price dropped by $13.96, or over 18%, from $77.34 to $63.38 per share [3]. - On August 4, 2025, the company announced disappointing quarterly consumption figures for Premier Protein RTD Shakes, leading to a further decline in stock price by $17.46, or nearly 33%, from $53.64 to $36.18 per share [4].

Core Viewpoint - CarMax, Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims regarding its assessment of car loan risks [1][2]. Financial Performance - CarMax reported a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units for Q2 of fiscal year 2026 [4]. - The company's net earnings for Q2 were approximately $95.4 million, down from $132.8 million in the previous year [4]. - A significant factor for the declines was identified as a "pull forward" in demand due to U.S. tariffs, which led to a loan loss provision of $142.2 million in the financing segment, resulting in an 11.2% year-over-year decrease in income from this segment [4]. Stock Market Reaction - Following the announcement of its disappointing financial results, CarMax's stock price fell by $11.45 per share, approximately 20%, from $57.05 on September 24, 2025, to $45.60 on September 25, 2025 [5]. Investigation Context - The investigation stems from claims that CarMax misrepresented the sustainability of demand for its vehicles and failed to properly assess the risks associated with its car loans [2][3].

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1] Group 1: Fortinet, Inc. (NASDAQ: FTNT) - Class period is from November 8, 2024, to August 6, 2025, with a lead plaintiff deadline of November 21, 2025 [2] - Allegations include false and misleading statements regarding the refresh cycle's profitability, lack of clarity on upgradeable FortiGate firewalls, and misrepresentation of the refresh momentum [2] Group 2: Molina Healthcare, Inc. (NYSE: MOH) - Class period is from February 5, 2025, to July 23, 2025, with a lead plaintiff deadline of December 2, 2025 [3] - Allegations include failure to disclose adverse facts about medical cost trend assumptions, dependency on low utilization of services for growth, and likely cuts to financial guidance for fiscal year 2025 [3] Group 3: Marex Group plc (NASDAQ: MRX) - Class period is from May 16, 2024, to August 5, 2025, with a lead plaintiff deadline of December 8, 2025 [4] - Allegations include selling over-the-counter financial instruments to itself, inconsistencies in financial statements, and unreliability of Marex's financial disclosures [4]

Core Viewpoint - Fluor Corporation is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 18, 2025, and July 31, 2025 [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Fluor Corporation concealed rising costs associated with infrastructure projects, including Gordie Howe, I-635/LBJ, and I-35, due to subcontractor design errors, price increases, and scheduling delays [2]. - It is alleged that these issues, along with reduced capital spending from customers and economic uncertainty, significantly affected the Company's business and financial results [2]. - The financial guidance provided by Fluor for FY 2025 is claimed to be unreliable and overstated regarding the effectiveness of its risk mitigation strategy and the impact of economic uncertainty [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until November 14, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate in the lawsuit [3]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [4].

Core Viewpoint - A class action lawsuit has been filed against Baxter International Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International Inc., et al., No. 1:25-cv-12672 [3]. - Investors have until December 15, 2025, to request to be appointed to lead the case [3]. Group 2: Product Issues - Baxter's Novum IQ Large Volume pump, a key growth driver, faced serious malfunctions after its launch in Canada, including under-infusion and over-infusion of medications [4][5]. - The company previously claimed that the Novum LVP had advanced safety features and that the Canadian rollout would help resolve any issues [5]. Group 3: Stock Impact - Following the announcement on July 31, 2025, to pause shipments and installations of the Novum LVP, Baxter's stock price dropped by $6.29, or over 22%, from $28.05 to $21.76 per share [6].